SAN DIEGO, Feb. 15, 2018 — Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of A. Schulman, Inc. (NASDAQ: SHLM) (“A. Schulman”) breached their fiduciary duties in connection with the proposed sale of the Company to LyondellBasell Industries N.V. (NYSE: LYB) (“LyondellBasell”).
On February 15, 2018, A. Schulman announced that it had signed a definitive merger agreement with LyondellBasell. Under the terms of the agreement, A. Schulman shareholders will receive $42 per share in cash and one contingent value right per share.
The investigation concerns whether the A. Schulman board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for A. Schulman shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst has a $45.00 price target on the stock.
If you are a shareholder of A. Schulman and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker ([email protected]) at 619-814-4471. If emailing, please include a phone number.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
SOURCE Johnson Fistel, LLP
Latest posts by Sarah Thompson (see all)
- Frenkel & Company – an EPIC Company's Michael Feinstein to Present on Cyber Liability at American Truck Dealers 20 Group Meeting - February 19, 2018
- AAD 2018: Treatment with Lilly's TaltzÂ® (ixekizumab) Resulted in Improvement in Impact of Genital Psoriasis on Sexual Activity - February 19, 2018
- "Spanish Serenade" by Tatiana Mikova Featured on "Performance Today" (American Public Media) - February 19, 2018